AINewsnow

Novo will test Anthropic’s Claude Science to speed up drug discovery

This story is from 2026-09-16. It is preserved in the archive; the latest stories are on the live feed.

“Joining forces with Anthropic will supercharge our R&D organisation and help us on our mission to bring new, transformative health solutions to people living with chronic diseases,” said Mike Doustdar, president and chief executive of Novo. The Danish drugmaker, formerly branded Novo Nordisk, and…

Read the full story at The Next Web ↗

Timeline · 1 report

  1. 2026-09-16 16:16 · The Next Web
    Novo will test Anthropic’s Claude Science to speed up drug discovery

More stories

  1. AI's role in building AI surging? Anthropic says Claude now leads 26% of its R&D — Mint AI
  2. Hackers Used Anthropic’s Claude to Break Into OpenAI — Wall Street Journal Technology
  3. Anthropic adds support for the AGENTS.md instructions spec to Claude Code; OpenAI contributed AGENTS.md to the Agentic AI Foundation last year (Thomas Claburn/The Register) — Techmeme
  4. Claude, Anthropic’s AI model, is helping to develop the next version of itself — Fast Company AI
  5. Minimax H3 template Missing. — r/comfyui
  6. OpenAI ‘ethically hacked’ with help of Anthropic’s Claude chatbot — The Guardian AI
  7. Mathematicians Hate AI. They Can’t Quit It — Wired AI
  8. Anthropic Shifts Planned IPO to November — Wall Street Journal Technology

Get the daily brief of stories like this at 6:30 every morning →